RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022)
RedHill Biopharma (RDHL) reported Exchange Rate Effect of -$16000.0 for Q4 2022, down 277.78% year-over-year from $9000.0 in Q4 2021, and down 23.08% quarter-over-quarter from -$13000.0 in Q3 2022.
RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 11 years of Exchange Rate Effect data on file, last reported at -$16000.0 in Q4 2022.
- Exchange Rate Effect for Q4 2022 came in at -$16000.0, down 277.78% year-over-year; the trailing twelve-month figure through Dec 2022 was -$76000.0 (up 21.65% YoY), and the FY2025 annual result was -$2000.0, down 122.22% from the prior year.
- Exchange Rate Effect eased to -$16000.0 in Q4 2022 per RDHL's latest filing, from -$13000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $131000.0 in Q1 2020 and troughed at -$103000.0 in Q1 2021.
- A 5-year average of -$2650.0 and a median of -$13500.0 in 2018 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 718.75% in 2020 and fell as far as 3400.0% in 2020.
- A 5-year view of Exchange Rate Effect shows it stood at -$16000.0 in 2018, then soared by 437.5% to $54000.0 in 2019, then tumbled by 83.33% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then tumbled by 277.78% to -$16000.0 in 2022.
- Business Quant data shows RDHL's Exchange Rate Effect at -$16000.0 in Q4 2022, -$13000.0 in Q3 2022, and -$32000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -16,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | -33,000.00 |
| Sep 30, 2020 | -33,000.00 |